DUBLIN--(BUSINESS WIRE)--The "Pancreatic Cancer Therapy Market to 2025 - Global Analysis and Forecasts By Type, Therapy and Geography" report has been added to ResearchAndMarkets.com's offering.
The global pancreatic cancer therapy market is expected to reach US$ 4,056.4 Mn in 2025 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8.1% from 2018-2025.
Key Topics Covered:
1. Introduction
2. Global Pancreatic Cancer Therapy Market - Key Takeaways
3. Global Pancreatic Cancer Therapy Market - Market Landscape
4. Global Pancreatic Cancer Therapy Market - Key Market Dynamics
5. Pancreatic Cancer Therapy Market - Global Analysis
6. Pancreatic Cancer Therapy Market Analysis- by Type
7. Global Pancreatic Cancer Therapy Market Analysis- by Therapy
8. North America Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025
9. Europe Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025
10. Asia Pacific Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025
11. Middle East and Africa Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025
12. South and Central America Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025
13. Pancreatic Cancer Therapy Market - Industry Landscape
14. Pancreatic Cancer Therapy Market - Key Company Profiles
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Celgene Corporation
- Amgen Inc.
- Novartis AG
- Pharmacyte Biotech Inc.
- Clovis Oncology
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Merck & Co., Inc.